Myriad Genetics OverviewMyriad Genetics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for MYGN.
Quarterly EBIT
-$30.00M
↓ 4.9% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$386.00M
↓ 218.74% YoY
Trailing 12 months ending Mar 31, 2026
Myriad Genetics OverviewEBIT (Earnings Before Interest and Taxes) analysis for MYGN.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026